stars 1 stars 2 stars 3

MedGenome is a global genomics and precision diagnostics company focused on enabling accurate, early and actionable diagnosis through advanced genomic science. We operate South Asia’s largest CAP-accredited genetic testing laboratory and offer a comprehensive test menu of more than 1,300 genetic assays across key disease areas. Our diagnostic capabilities span rare inherited disorders, oncology, reproductive health, infectious diseases and preventive wellness. By integrating next-generation sequencing technologies with proprietary assays and AI-enabled bioinformatics platforms, MedGenome delivers high-quality genomic insights that support clinicians in complex clinical decision-making. Founded with a vision to make genomic healthcare affordable and accessible, MedGenome has built deep scientific and clinical expertise backed by extensive research and global collaborations. Our work is supported by a strong research foundation with hundreds of peer-reviewed scientific publications, reflecting our commitment to evidence-based diagnostics and innovation. MedGenome serves clinicians and healthcare institutions across hundreds of locations in India and multiple countries worldwide. Our team of scientists, genome analysts, bioinformaticians and clinical experts works closely with healthcare providers to ensure test accuracy, clinical relevance and timely reporting. We are driven by a commitment to continuous innovation, quality and education. From developing in-house genomics solutions to advancing awareness around genetic testing, MedGenome plays an active role in shaping the future of precision medicine. At MedGenome, every genome decoded strengthens our mission to improve patient outcomes, support clinicians with reliable insights and transform healthcare through the power of genomics.

Website http://www.medgenome.com
Revenue $84.4 million
Funding $159 million
Employees 1,040 (677 on RocketReach)
Founded 2013
Phone +91 65043 48282
Technologies
Industry Biotechnology Research, Business Services General, Biotechnology, Integrated Genomics Platform, Business Services, Science and Engineering, Onsite next-generation sequencing, Genetics, Population studies and panel assembly, Health Care, Rescuing and repurposing compounds & biologics, Medical, WGS, WES, RNA Seq, Mirna Seq, Chip Seq, MethylSeq, TCR Seq, NGS Bioinformatics, Immunotherapy Solutions
Keywords Biomarker Discovery, Genomic Diagnostics, Genomics Research, Personalized Medicine, Precision Medicine, Clinical Genomics, Molecular Diagnostics, Genetic Testing, Genome Sequencing, Next Generation Sequencing, Dna Sequencing, Drug Discovery, Ngs, Genetic Analysis, Dna Analysis, Pharmaceutical Research, Medical Diagnostics, Healthcare Technology, Biotechnology, Life Sciences
Competitors Invitae, Illumina, Fulgent Genetics, Quest Diagnostics, GENOOX, 23andMe Inc, Myriad Genetics, GeneDx, Ambry Genetics, Sema4 +41 more (view full list)
SIC SIC Code 873 Companies, SIC Code 87 Companies
NAICS NAICS Code 541713 Companies, NAICS Code 541 Companies, NAICS Code 54171 Companies, NAICS Code 5417 Companies, NAICS Code 54 Companies

MEDGENOME Questions

The MEDGENOME annual revenue was $84.4 million in 2026.

Vedam Ramprasad is the Chief Executive Officer (India) of MEDGENOME.

677 people are employed at MEDGENOME.

The NAICS codes for MEDGENOME are [541713, 541, 54171, 5417, 54].

The SIC codes for MEDGENOME are [873, 87].

Top MEDGENOME Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users